Literature DB >> 11895980

Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background.

Abdallah F Elias1, Philip E Stewart, Dorothee Grimm, Melissa J Caimano, Christian H Eggers, Kit Tilly, James L Bono, Darrin R Akins, Justin D Radolf, Tom G Schwan, Patricia Rosa.   

Abstract

A major obstacle to studying the functions of particular gene products in the mouse-tick infectious cycle of Borrelia burgdorferi has been an inability to knock out genes in pathogenic strains. Here, we investigated conditions for site-directed mutagenesis in B31 MI, the low-passage-number, infectious B. burgdorferi strain whose genome was sequenced. We inactivated several plasmid and chromosomal genes in B31 MI and determined that clones carrying these mutations were not infectious for mice. However, we found extensive heterogeneity among clones and mutants derived from B31 MI based on colony phenotype, growth rate, plasmid content, protein profile, and transformability. Significantly, several B31 MI clones that were not subjected to mutagenesis but that lacked particular plasmids also exhibited defects at various stages in the infectious cycle. Therefore, the high degree of clonal polymorphism within B31 MI complicates the assessment of the contributions of individual genes to the observed phenotypes of the mutants. Our results indicate that B31 MI is not an appropriate strain background for genetic studies in infectious B. burgdorferi, and a well-defined isogenic clone is a prerequisite for targeted mutagenesis. To this end, we derived several wild-type clones from B31 MI that were infectious for mice, and gene inactivation was successful in one of these clones. Due to the instability of the genome with in vitro propagation, careful monitoring of plasmid content of derived mutants and complementation of inactivated genes will be crucial components of genetic studies with this pathogen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895980      PMCID: PMC127854          DOI: 10.1128/IAI.70.4.2139-2150.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

Review 1.  Lyme borreliosis: relation of its causative agent to its vectors and hosts in North America and Europe.

Authors:  R S Lane; J Piesman; W Burgdorfer
Journal:  Annu Rev Entomol       Date:  1991       Impact factor: 19.686

2.  Variations in the ospB gene of Borrelia burgdorferi result in differences in monoclonal antibody reactivity and in production of escape variants.

Authors:  J L Coleman; R C Rogers; P A Rosa; J L Benach
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

3.  Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice.

Authors:  T G Schwan; J Piesman
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  Antibody to a 39-kilodalton Borrelia burgdorferi antigen (P39) as a marker for infection in experimentally and naturally inoculated animals.

Authors:  W J Simpson; W Burgdorfer; M E Schrumpf; R H Karstens; T G Schwan
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

5.  A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction.

Authors:  P A Rosa; T G Schwan
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

6.  Evasion of protective immunity by Borrelia burgdorferi by truncation of outer surface protein B.

Authors:  E Fikrig; H Tao; F S Kantor; S W Barthold; R A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Distribution and molecular analysis of Lyme disease spirochetes, Borrelia burgdorferi, isolated from ticks throughout California.

Authors:  T G Schwan; M E Schrumpf; R H Karstens; J R Clover; J Wong; M Daugherty; M Struthers; P A Rosa
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

8.  An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo.

Authors:  A Sadziene; A G Barbour; P A Rosa; D D Thomas
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Recombination between genes encoding major outer surface proteins A and B of Borrelia burgdorferi.

Authors:  P A Rosa; T Schwan; D Hogan
Journal:  Mol Microbiol       Date:  1992-10       Impact factor: 3.501

10.  Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.

Authors:  S J Norris; C J Carter; J K Howell; A G Barbour
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

View more
  216 in total

1.  Analysis of a Borrelia burgdorferi phosphodiesterase demonstrates a role for cyclic-di-guanosine monophosphate in motility and virulence.

Authors:  Syed Z Sultan; Joshua E Pitzer; Michael R Miller; Md A Motaleb
Journal:  Mol Microbiol       Date:  2010-04-27       Impact factor: 3.501

2.  Antibiotic resistance markers for genetic manipulations of Leptospira spp.

Authors:  Dante Poggi; Priscila Oliveira de Giuseppe; Mathieu Picardeau
Journal:  Appl Environ Microbiol       Date:  2010-05-28       Impact factor: 4.792

3.  Borrelia host adaptation Regulator (BadR) regulates rpoS to modulate host adaptation and virulence factors in Borrelia burgdorferi.

Authors:  Christine L Miller; S L Rajasekhar Karna; J Seshu
Journal:  Mol Microbiol       Date:  2013-03-14       Impact factor: 3.501

4.  Borrelia burgdorferi sigma54 is required for mammalian infection and vector transmission but not for tick colonization.

Authors:  Mark A Fisher; Dorothee Grimm; Amy K Henion; Abdallah F Elias; Philip E Stewart; Patricia A Rosa; Frank C Gherardini
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-02       Impact factor: 11.205

5.  Borrelia oxidative stress response regulator, BosR: a distinctive Zn-dependent transcriptional activator.

Authors:  Julie A Boylan; James E Posey; Frank C Gherardini
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-15       Impact factor: 11.205

6.  The etiological agent of Lyme disease, Borrelia burgdorferi, appears to contain only a few small RNA molecules.

Authors:  Yngve Ostberg; Ignas Bunikis; Sven Bergström; Jörgen Johansson
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

7.  aadA confers streptomycin resistance in Borrelia burgdorferi.

Authors:  Kristi L Frank; Sharyl F Bundle; Michele E Kresge; Christian H Eggers; D Scott Samuels
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

8.  Functional Equivalence of OspA and OspB, but Not OspC, in Tick Colonization by Borrelia burgdorferi.

Authors:  Kit Tilly; Aaron Bestor; Patricia A Rosa
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

9.  Global transcriptome analysis of Borrelia burgdorferi during association with human neuroglial cells.

Authors:  Jill A Livengood; Virginia L Schmit; Robert D Gilmore
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

10.  Role of Borrelia burgdorferi linear plasmid 25 in infection of Ixodes scapularis ticks.

Authors:  Keith O Strother; Aravinda de Silva
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.